Navigation Links
Solutia Reports First Quarter 2009 Results
Date:5/6/2009

utable to non-controlling interest and reorganization items, net) and Adjusted EBITDA (to include EBITDA and exclude gains and losses, cost overhang associated with the expected sale of our Integrated Nylon business, and non-cash stock compensation expense) that are not determined in accordance with generally accepted accounting principles in the United States (GAAP). The company believes that these non-GAAP financial measures are useful to investors because they facilitate period-to-period comparisons of Solutia's performance and enable investors to assess the company's performance in the way that management and lenders do. Our debt covenants and certain management reporting and incentive plans are measured against certain of these non-GAAP financial measures. Reconciliations of these measures to GAAP measures are included immediately below.

Reconciliation of Income (Loss) from Continuing Operations to Adjusted

EBITDA from Continuing Operations 

                             Successor   Predecessor    Successor   Combined
                             ---------   -----------    ---------   --------
                               Three        Two           One         Three
                               Months       Months        Month       Months
                               Ended        Ended         Ended       Ended
                              March 31,   February 29,   March 31,   March 31,
    (dollars in millions)       2009         2008          2008        2008
                             ----------  -------------  ----------   --------
    Income (Loss) from
     Continuing
     Operations                 $(4)        $1,250        $(16)      $1,234
    Plus:
      Income Tax (Benefit)
       Expense                   (7)           214           -          214
      Interest Expense           37             21          17           38
      Depreciation and
       Amorti
'/>"/>
SOURCE  Solutia Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 

Related biology technology :

1. Solutia to Present at Deutsche Bank Small and Mid Cap Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Cellular Biomedicine Group (OTCQB: CBMG) ... of the total projected enrollment required for its ... preliminary efficacy of the medical technology haMPC (Human ... (KOA). To date the trial has had no ... Phase I open label clinical research trial for ...
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 RURO ... ezColony version 4.1, a versatile refinement to the ... software solution, improves its advanced methodical management for ... with ezColony 4.1. The network-based platform provides user ... effective research. While continuing to emphasize streamlined tasks, ...
(Date:5/17/2013)... Darrington, WA (PRWEB) May 17, 2013 Tooth ... 5th graders showing active signs of the disease. The World ... children and nearly 100% of adults have cavities. What are ... Research is showing a strong connection between the oral ... why is this disease so rampant, yet it is also ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded ... the earnings conference call for the fiscal year 2011 ... a.m. Eastern Time on Tuesday, September 27, 2011. ...
... SAN DIEGO, Sept. 20, 2011 The J. ... institute, today held an official groundbreaking ceremony for ... by ZGF Architects, will be a state-of-the-art, "ultra-green" ... computational laboratory building on the University of California, ...
... 20, 2011 SomaGenics, Inc., a biotechnology company specializing ... of RNA interference (RNAi) therapeutics against Hepatitis C virus ... SomaGenics, along with its collaborators at Tekmira Pharmaceuticals ... "Synthetic Short shRNAs are Potent Inhibitors of Hepatitis C ...
Cached Biology Technology:TPI to Host Fiscal Year 2011 Earnings Conference Call on Tuesday, September 27, 2011 at 9:00 a.m. ET 2J. Craig Venter Institute Breaks Ground on La Jolla, California's First True Sustainable Laboratory Facility 2J. Craig Venter Institute Breaks Ground on La Jolla, California's First True Sustainable Laboratory Facility 3SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus 2SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus 3
(Date:5/17/2013)... study finds human-caused climate change may have little ... a host of recent studies that predict their ... The findings, which appear in the journal ... survival of a creature thought to be doomed: ... cold-blooded animals, especially forest lizards, will be hard ...
(Date:5/16/2013)... (May 17, 2013) Illustrating a commitment to ... American Gastroenterological Association (AGA) Research Foundation has announced ... Research Fellowship Award recipients. Supported by the National ... (NIDDK), this new award helps underrepresented minority students ... and nutrition research. , "By establishing this new ...
(Date:5/16/2013)... to a fast food restaurant had a higher body ... from fast food, according to researchers at The University ... was particularly strong among those with a lower income. ... American Journal of Public Health indicates higher ... restaurant, and among lower-income African-Americans, the density, or number, ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... first time created 3D models of whole intact mouse ... team reports its findings in the May/June issue of ... study published online this week. Combining an ... uses a solution that renders tissue transparent, the researchers ...
... deep ocean animal communities can undergo rapid, widespread and ... are at the forefront of monitoring these changes and ... in a special issue of the journal Deep ... the deep ocean floor as stable, relatively unvarying environment ...
... release is available in German . , ... - a North African bird species with a very ... from attractive males of the same species positively affects ... highly displaying male birds in the experiment were more ...
Cached Biology News:Scientists create 3-D models of whole mouse organs 2Ecological change in the abyss -- the Amperima event 2Ecological change in the abyss -- the Amperima event 3Pleasing to the eye 2Pleasing to the eye 3
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
pETDuet-1 is designed for the coexpression of two target genes....
Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...
Mouse Laminin-1 MAb (Clone AL-3)...
Biology Products: